de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLOS Med. 2016;13: e1002184.

Article  PubMed  PubMed Central  Google Scholar 

Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet Lond Engl. 2022;399:629–55.

Article  Google Scholar 

Murray, C. J. L. et al.Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet Lond Engl. 2022;399:629–55.

Chung M, Yeh I, Sung L, Wu M, Chao Y, Ng I, et al. Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9. Biotechnol Bioeng. 2017;114:172–83.

Article  CAS  PubMed  Google Scholar 

Tao S, Chen H, Li N, Liang W. The application of the CRISPR-Cas system in antibiotic resistance. Infect Drug Resist. 2022;15:4155–68.

Article  PubMed  PubMed Central  Google Scholar 

Shetty VP, Akshay SD, Rai P, Deekshit VK. Integrons as the potential targets for combating multidrug resistance in Enterobacteriaceae using CRISPR- Cas9 technique. J Appl Microbiol. 2023;134: lxad137.

Article  PubMed  Google Scholar 

Wu Z-Y, Huang Y-T, Chao W-C, Ho S-P, Cheng J-F, Liu P-Y. Reversal of carbapenem-resistance in Shewanella algae by CRISPR/Cas9 genome editing. J Adv Res. 2019;18:61–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8:162–73.

Article  PubMed  PubMed Central  Google Scholar 

Janik E, Niemcewicz M, Ceremuga M, Krzowski L, Saluk-Bijak J, Bijak M. Various aspects of a gene editing system—crispr–cas9. Int J Mol Sci. 2020;21:9604.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y-Z, Kuang X, Long T-F, Li G, Ren H, He B, et al. Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli. J Antimicrob Chemother. 2022;77:74–82.

Article  CAS  Google Scholar 

Lone BA, Karna SKL, Ahmad F, Shahi N, Pokharel YR. CRISPR/Cas9 system: a bacterial tailor for genomic engineering. Genet Res Int. 2018. https://doi.org/10.1155/2018/3797214.

Article  PubMed  PubMed Central  Google Scholar 

Kim J-S, Cho D-H, Park M, Chung W-J, Shin D, Ko KS, et al. CRISPR/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum β-lactamases. J Microbiol Biotechnol. 2016;26:394–401.

Article  CAS  PubMed  Google Scholar 

Mojica FJ, Díez-Villaseñor C, Soria E, Juez G. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol. 2000;36:244–6.

Article  CAS  PubMed  Google Scholar 

Jansen R, van Embden JD, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol. 2002;43:1565–75.

Article  CAS  PubMed  Google Scholar 

Hille F, Charpentier E. CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc B Biol Sci. 2016;371:20150496.

Article  Google Scholar 

Nuñez JK, Kranzusch PJ, Noeske J, Wright AV, Davies CW, Doudna JA. Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity. Nat Struct Mol Biol. 2014;21:528–34.

Article  PubMed  PubMed Central  Google Scholar 

Le Rhun A, Escalera-Maurer A, Bratovič M, Charpentier E. CRISPR-Cas in Streptococcus pyogenes. RNA Biol. 2019;16:380–9.

Article  PubMed  PubMed Central  Google Scholar 

Teng M, Yao Y, Nair V, Luo J. Latest advances of virology research using CRISPR/Cas9-based gene-editing technology and its application to vaccine development. Viruses. 2021;13:779.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017;37:67–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016;353: aaf5573.

Article  PubMed  PubMed Central  Google Scholar 

Alduhaidhawi AHM, AlHuchaimi SN, Al-Mayah TA, Al-Ouqaili MT, Alkafaas SS, Muthupandian S, et al. Prevalence of CRISPR-cas systems and their possible association with antibiotic resistance in Enterococcus faecalis and Enterococcus faecium collected from hospital wastewater. Infect Drug Resist. 2022;15:1143–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hullahalli K, Rodrigues M, Schmidt BD, Li X, Bhardwaj P, Palmer KL. Comparative analysis of the orphan CRISPR2 locus in 242 Enterococcus faecalis strains. PLoS One. 2015;10: e0138890.

Article  PubMed  PubMed Central  Google Scholar 

Hullahalli K, Rodrigues M, Nguyen UT, Palmer K. An attenuated CRISPR-Cas system in Enterococcus faecalis permits DNA acquisition. MBio. 2018. https://doi.org/10.1128/mbio.00414-18.

Article  PubMed  PubMed Central  Google Scholar 

Burley KM, Sedgley CM. CRISPR-Cas, a prokaryotic adaptive immune system, in endodontic, oral, and multidrug-resistant hospital-acquired Enterococcus faecalis. J Endod. 2012;38:1511–5.

Article  PubMed  Google Scholar 

Hullahalli K, Rodrigues M, Palmer KL. Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations. Elife. 2017;6: e26664.

Article  PubMed  PubMed Central  Google Scholar 

Gholizadeh P, Aghazadeh M, Ghotaslou R, Rezaee MA, Pirzadeh T, Cui L, et al. Role of CRISPR-Cas system on antibiotic resistance patterns of Enterococcus faecalis. Ann Clin Microbiol Antimicrob. 2021;20:1–12.

Article  Google Scholar 

Zhou Y, Yang Y, Li X, Tian D, Ai W, Wang W, et al. Exploiting a conjugative endogenous CRISPR-Cas3 system to tackle multidrug-resistant Klebsiella pneumoniae. EBioMedicine. 2023;88: 104445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinkunas T, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 2011;30:1335–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. The Tat inhibitor didehydro-cortistatin A prevents HIV-1 reactivation from latency. MBio. 2015. https://doi.org/10.1128/mbio.00465-15.

Article  PubMed  PubMed Central  Google Scholar 

Selle K, Fletcher JR, Tuson H, Schmitt DS, McMillan L, Vridhambal GS, et al. In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials. MBio. 2020;11: e00019-20.

Article  PubMed  PubMed Central  Google Scholar 

Yosef I, Manor M, Kiro R, Qimron U. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci. 2015;112:7267–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Kriz AJ, Sharp PA. Target specificity of the CRISPR-Cas9 system. Quant Biol. 2014;2:59–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao M, He Y, Zhang H, Liao X-P, Liu Y-H, Sun J, et al. CRISPR-Cas9-mediated carbapenemase gene and plasmid curing in carbapenem-resistant enterobacteriaceae. Antimicrob Agents Chemother. 2020;64:e00843-e920.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kyrou K, Hammond AM, Galizi R, Kranjc N, Burt A, Beaghton AK, et al. A CRISPR–Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat Biotechnol. 2018;36:1062–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahriar SA, Islam MN, Chun CNW, Rahim MA, Paul NC, Uddain J, et al. Control of plant viral diseases by CRISPR/Cas9: resistance mechanisms, strategies and challenges in food crops. Plants. 2021;10:1264.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hazafa A, Mumtaz M, Farooq MF, Bilal S, Chaudhry SN, Firdous M, et al. CRISPR/Cas9: a powerful genome editing technique for the treatment of cancer cells with present challenges and future directions. Life Sci. 2020;263: 118525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao R, Liu D, Jia X, Zheng Y, Liu W, Xiao Y. CRISPR-Cas9/Cas12a biotechnology and application in bacteria. Synth Syst Biotechnol. 2018;3:135–49.